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1. Introduction 
Incompletely characterized polypeptides display- 
ing somatostatin-like immunoreactivity (SLI) [l-4] 
and somatostatin-like biological activity [2], have 
been described in extracts of hypothalamus, extra- 
hypothalamic brain, stomach, and pancreas. Gel fil- 
tration studies have shown that the SLI exists in 
multiple molecular forms. Similarly, pulse-chase 
incubation experiments have shown incorporation 
of labeled amino acids into somatostatin-like poly- 
peptides in the 7000-13 000 mol. wt range in 
anglerfish islets [ 51 and in the > 150 000 and 3 500 mol. 
wt range in slices of rat hypothalamic and pancreatic 
tissue [6]. Immunoaffnity chromatography using 
immobilized antibodies directed against different 
regions of the somatostatin molecule has been 
employed to isolate and differentiate between the 
molecular forms of somatostatin-like immunoreactivity 
in canine plasma [7]. In this study we employ these 
methods to characterize the SLI present in extracts 
of canine pancreas with respect to molecular size, 
charge and immunometric properties. 
2. Materials and methods 
Trypsin insolubilized on polyacrylamide (250 U/g 
insoluble enzyme), horse cytochrome c, and DL-di- 
thiothreitol were purchased from Sigma Chemical 
Company, St Louis. Antiserum S-27, directed against 
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residues 5-9 and 11 [ 81, and antiserum S-8 1, directed 
against residues l-4 of somatostatin [8], were pro- 
vided by Dr W. Vale, Salk Institute, La Jolla. Anti- 
bodies from these antisera were immobilized on 
cyanogen bromide activated Sepharose-4B as in [9]. 
The pancreases of normal dogs were removed 
immediately after sacrifice and frozen on solid CO*. 
Tissue extracts were prepared by a modification of 
the method in [lo]. Minced pancreatic tissue was 
heated to 90°C for 5 min in 2 M acetic acid, rapidly 
cooled and homogenized in a Waring blender. The 
crude tissue extracts were centrifuged at 2500 rev./ 
min for 15 min and the supernatant adjusted to 
pH 7.4 with 10 M sodium hydroxide solution. After 
further centrifugation at 2500 rev./min for 15 min, 
the supernatant was chromatographed on columns 
of immobilized antibodies S-27 and S-81 as in [9]. 
After elution of non-biospecifically adsorbed mate- 
rial by irrigation with 1 M NaCl adjusted to pH 10.4 
with aqueous ammonia (spec. grav. 0.88) [ 111, the 
SLI bound to antibody was recovered by irrigation 
with 1 M formic acid. Fractions containing SLI 
were lyophilized and subjected to gel fdtration on 
columns (60 X 2.5 cm) of Biogel P-10 using 0.1 M 
N&HCOs, pH 8.8, for elution. Fractions containing 
SLI were again lyophilized and subjected to isoelec- 
tric focusing at 4’C using an LKB Model 8100 iso- 
electric focusing column (110 ml) [ 121. Linear pH 
gradients in the pH 3.5-10 and pH 9-l 1 ranges 
were generated in sorbitol density gradients con- 
taining 2%, v/v, LKB ampholines. pH measurements 
were made at 4°C using a Beckman Model 3550 pH 
meter. Horse cyctochrome c (PI 10.04 _+ 0.04 at 
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20°C) [ 131, was included in the pH 9-l 1 gradients 
to monitor the reproducibility of different isoelec- 
tric focusing runs. Tryptic digestion of SLI frac- 
tions was carried out in 0.2 M NH4HC0a buffer (pH 8.2) 
at 25°C using insoluble trypsin at 2 X 10e2 units/nmol 
SLI. The reaction was terminated by centrifugation 
and removal of the supernatant. Fractions of SLI in 
6 M guanidinium hydrochloride (recrystallized) were 
treated with lOO-fold molar excess of dithiothreitol 
at 5O’C for 3 h in an atmosphere of N2. The reaction 
mixture was chromatographed on columns of Biogel 
P-10, at pH 8.8. SLI was measured by the radio- 
immunoassay procedure in [ 141 as modified [9] 
using Arimura antiserum Rl 01 which is directed 
toward the same region of the somatostatin mole- 
cule as antiserum S-27. 
3. Results and discussion 
Over 95% SLI was removed from extracts of canine 
pancreas by passage through columns of immobilized 
antibodies specific for the central residues of somato- 
statin (antibody S-27), but only 1 O-20% SLI was 
removed by passage through the column of antibodies 
specific for the N-terminal region of somatostatin 
(antibody S-81). In contrast, > 95% immunoreac- 
tivity associated with synthetic somatostatin in protein- 
free buffer (at the same concentration of immuno- 
reactivity as in the pancreatic extracts) was bound by 
both antibody conjugates. The elution profiles of the 
immunoreactive material recovered from immuno- 
affinity columns are shown in fig.1. SLI isolated with 
the antibody S-27 column was eluted as 3 peaks in 
the regions of mol. wt 12 000,350O and 1600 (approx. 
relative abundance 10:5:200) (fig.lA), but SLI 
recovered from the antibody S-81 column was eluted 
as a single peak in the 1600 mol. wt region (fig.lB). 
The fact that the N-terminally directed antibody con- 
jugate S-8 1 shows reduced binding of pancreatic SLI 
relative to synthetic somatostatin may indicate that 
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Fig.1. Elution profile of SLI from canine pancreatic extracts on Biogel P-10 columns of pH 8.8: (A) After recovery from columns 
of immobilized antibodies specific for the N-terminal region of somatostatin (residues l-4); (B) after recovery from columns of 
immobilized antibodies specific for the central region of somatostatin (residues 5-9 and 11). The serrated peak in B indicates that 
the levels of immunoreactivity could not be accurately measured without further dilution of the fractions. The arrows indicate the 
elution volumes of blue dextran (M ,), cytochrome c (M,), synthetic somatostatin (M,) and potassium chromate Of,). 
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the N-terminal residues of SLI are rendered inacces- 
sible to antibody by interaction with proteins in the 
pancreatic extract. The presence of proteins that 
bind SLI has been demonstrated in tissues [ 151 and 
plasma [7,9]. The elution volume of the 12 000 mol. 
wt and 3500 mol. wt SLI components on Biogel P-10 
at pH 8.8 were unaffected by incubation of the SLI 
with 8 M urea or with 6 M guanidinium hydrochloride, 
indicating that these forms of SLI were not aggregates 
of the 1600 mol. wt SLI or non-covalently bound 
complexes of the 1600 mol. wt polypeptide with 
nonimmunoreactive material. The elution profile of 
the 3500 mol. wt component was unchanged after 
treatment with dithiothreitol under conditions which 
are known to cleave both intra- and intermolecular 
disulfide linkages [ 161 but after similar treatment of 
the 12 000 mol. wt component all the immuno- 
reactivity was eluted from Biogel P-10 columns in 
the 1600 mol. wt zone (fig.2). 
The molecular charges and immunometric proper- 
ties of the pancreatic SLI fractions were compared 
with those of synthetic somatostatin. Both the 
3500 mol. wt and 1600 mol. wt fractions were iso- 
electrically focused to single immunoreactive bands 
in the same pH region as synthetic somatostatin 
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Fig.2. Elution profile of the 12 000 mol. wt pancreatic SLI 
component on Biogel P-10 columns at pH 8.8: (A) After 
incubation with 6 M guanidinium hydrochloride; (B) after 
incubation with 6 M guanidinium hydrochloride containing 
dithiothreitol. The arrows indicate the elution volumes of 
blue dextran (M,). cytochrome c (M,) and synthetic somato- 
statin (MJ. 
(pH 10.5), whereas the 12 000 mol. wt polypeptide 
was focused into two bands at pH 4.6 and pH 5.7. 
Serial dilutions of the 12 000,350O and 1600 mol. wt 
SLI fractions from the pancreas were proportional 
and the dilution slopes were parallel to that of syn- 
thetic somatostatin in a radioimmunoassay using 
Arimura antiserum RlOl (fig.3). Thus, the pre- 
dominant molecular species of SLI in the pancreas 
resembles the tetradecapeptide, somatostatin, with 
respect to its molecular size, charge and immuno- 
metric properties. 
The effect of incubation of the 3500 mol. wt SLI 
with immobilized trypsin for a period of 10 min is 
shown in fig.4. After 10 min, immunoreactivity was 
eluted from Biogel P-10 columns in the 1600 mol. wt 
as well as in the 3500 mol. wt zone. Trypsin-like 
enzymes have been implicated in the conversion of 
high molecular weight biologically inactive precursor 
molecules to the biologically-active hormone in a wide 
variety of systems [ 17-2 l] and these results are 
consistent with a possible role of the 3500 mol. wt 
SLI as a precursor of pancreatic somatostatin. The 
conversion of the 12 000 mol. wt SLI component 
into the 1600 mol. wt component by dithiothreitol 
suggests that this large molecular weight component 
may represent a post-translational modification of the 
1600 mol. wt component by binding to a nonimmuno- 
reactive polypeptide via a disulfide linkage. While this 
Fig.3. Dilution slopes of pancreatic SLI components of 
12 000 mol. wt (m-m-m), 3500 mol. wt (A-A-A) and 
1600 mol. wt (e-•-•-) in comparison to serial dilutions 
of synthetic somatostatin (o-o-o). The pancreatic SLI 
samples were purified by affinity chromatography and gel 
filtration. 
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l:ig.4. Elution profile of the 3500 mol. wt pancreatic SLI 
component on Biogel P-10 columns at pH 8.8: (A) After 
incubation with 6 M guanidinium hydrochloride containing 
dithiothreltol; (B) after incubation with insolubilized 
trypsin. Experimental details are given in the text. The 
arrows indicate the elution volumes of blue dextran (M,). 
cytochrome c (M,) and synthetic somatostatin (M,). 
investigation was in progress, a 12 000 mol. wt poly- 
peptide, displaying somatostatin-like immunoreactivity 
and with similar physicochemical properties to the 
component described in this study, has been isolated 
from extracts of pigeon pancreas [22]. It has been 
shown that only the 1600 mol. wt component is 
released from the isolated perfused canine pancreas 
in response to an arginine stimulus [7] and the 
physiological significance of the 12 000 mol. wt 
component is not understood. 
Acknowledgements 
This work was supported by VA Institutional 
Research Support Grant 549-8000-01; National 
Institutes of Health Grant AM 02700-16 and 
contract NO1 -AM-622 19; and The Salk Institute- 
Texas Research Foundation. J. M. C. is the recipient 
of a Medical Research Council (London) Travelling 
Fellowship. 
References 
[ 1 ] Arimura, A., Sato. H., DuPont, A., Nishi, N. and 
Schally, A. V. (1975) Science 189,1007-1009. 
[ 21 Schally, A. V., DuPont, A., Arimura, A., Redding, 
T. W., Nlshi. N., Linthicum, G. L. and Schlesinger, 
D. H. (1976) Biochemistry 15, 509-514. 
[3] Kronheim, S.. Berelowitz, M. and Pimstone. B. L. 
(1976) Clin. Endocrinol. 5, 619-630. 
141 Pate], Y. and Reichlin, S. (1978) Endocrinology 102. 
523-530. 
[S] Noe, B. D.. Fletcher, D. J., Baner. G. E.. Weir, G. C. 
and Patel, Y. (1978) Endocrinology 102, 1675-1685. 
[6] Kanter, R.. Laschansky, E., Goodner, C. and Fnsinck, 
J. (1978) Clin. Res. 26, 159A. 
171 Conlon. J. hl.. Srikant, C. B., lpp. E., Schusdziarra, V. 
and Unger, R. H. (1978) Endocr. Sot. Prog. Abst. 
60th Annu. Meet., 194. 
[8] Vale, W.. Rlvier. J., Ling, N. and Brown, M. (1978) 
Metabolism (suppl. 1) 27. in press. 
[9] Hams, V., Conlon, J. M.. Srikant, C. B.. McCorkle. K.. 
Schusdziarra, V., lpp, E. and Ungcr. R. H. (1978) 
Clin. Chim. Acta 87. 275-283. 
[lo] Schally, A. V., Nair. R. M. G., Redding, T. W. and 
Arimura. A. (1971) J. Biol. Chem. 246, 7230-7236. 
[I 11 Murphy, R. F., Conlon, J. hf., lmam, A. and 
Kelly, G. J. 1~. (1977) J. Chromatography 135, 
42lm-433. 
[ 121 Srikant, C. B.. McCorkle, K. and Unger. R. 11. (1977) 
J. Biol. Chem. 252. 1847-1851. 
[ 131 Barlow, G. Ii. and Marpohash, I<. (1966) J. Biol. Chem. 
241.1473-1477. 
[14] Arlmura, A.,Sato. H.,Coy,D. H.and Schally, A. V. 
(1975) Proc. Sot Exp. Biol. Med. 148. 784-789. 
[ 15) Ogawa. N., Thompson. T.. Friesen. Il. G.. Martin, 
J.-B. and BrazeaulP. (1977) Riochem. J. 165. 
269-277. 
[I61 
[I71 
I181 
[I91 
1201 
[211 
LT.21 
Konigsberg. W. (1972) Methods Enzymol. 25. 
185-188. 
Steiner, D. I:.. Clar, J. L., Nolan. C.. Rubenstein. A. H.. 
Margoliash. I:., Aten, 1~. and Oyen. P. E. (1969) Rec. 
Prog. Horm. Res. 25.207-282. 
Yalow, R. S. and Berson, S. A. (1970) Gastroenterology 
58,609-615. 
Yalow, R. S. and Berson, S. A. (1971) Biochem. 
Biophys. Res. Commun. 44.439-445. 
Rigopoulou. D., Valverde, I., Marco, J., Faloona. G. and 
Unger, R. H. (1970) J. Biol. Chcm. 245.486-501. 
Kemperer, B., Habeuer, J. F.. Potts. J. and Rich. A. 
(1972) Proc. Natl. Acad. Sci. USA 69,643-647. 
Spiess. J. and Rivier. J. (1978) Endocr. Sot. Prog. Abst. 
60th Annu. Meet.. 151. 
330 
